Follow
International Journal of Current Microbiology and Applied Sciences (IJCMAS)
IJCMAS is now DOI (CrossRef) registered Research Journal. The DOIs are assigned to all published IJCMAS Articles.
Index Copernicus ICI Journals Master List 2022 - IJCMAS--ICV 2022: 95.28 For more details click here
National Academy of Agricultural Sciences (NAAS) : NAAS Score: *5.38 (2020) [Effective from January 1, 2020] For more details click here

Login as a Reviewer


See Guidelines to Authors
Current Issues
Download Publication Certificate

Original Research Articles                      Volume : 10, Issue:8, August, 2021

PRINT ISSN : 2319-7692
Online ISSN : 2319-7706
Issues : 12 per year
Publisher : Excellent Publishers
Email : editorijcmas@gmail.com /
submit@ijcmas.com
Editor-in-chief: Dr.M.Prakash
Index Copernicus ICV 2018: 95.39
NAAS RATING 2020: 5.38

Int.J.Curr.Microbiol.App.Sci.2021.10(8): 234-239
DOI: https://doi.org/10.20546/ijcmas.2021.1008.027


Individual Donor Nucleic Acid Testing for HIV, HBV and HCV among Blood Donors in a Tertiary Care Hospital
A. Shalini Priya1*, B. R. Sunitha2, K. S. Rajashekar3, R. Lava2, Mamatha Patil4,
Savitha Devi4 and Neelambika5
1Department of Microbiology, Government Karur Medical College, Karur-636 009,Tamil Nadu, India 2Department of Microbiology, 3Department of Pathology, J.J.M.Medical College, Davangere, India 4Blood Bank Officer, Chigateri District Hospital, Davangere, India 5Medical Superintendent Chigateri District Hospital, Davangere, India
*Corresponding author
Abstract:

Transfusion-transmitted infections (TTIs) continue to be a threat to safe transfusion practices. A total of 30 million blood components are transfused each year in India. Blood safety thus becomes a top priority, especially with a population of around 1.23 billion and a high prevalence rate of human immunodeficiency virus (HIV) in general population in India. Nucleic acid testing (NAT) in blood donor screening has been implemented in many developed countries to reduce the risk of transfusion-transmitted viral infections(TTIs). The objective was to assess the role of individual donor-NAT (ID-NAT) for human immunodeficiency virus-1 (HIV-1) its role in blood safety. It involves voluntary blood donors during period of one year from 1st June 2016 to May 2017 attending Chigateri Blood Bank, Davangere. Over a period of 1 year from 1st June 2016 to 31st May 2017, a total number of 9423 blood donor samples were subjected to test for HIV by Individual Donor Nucleic acid testing (ID-NAT), 9402 donors (99.8%) were negative by ID-NAT. 21 donors (0.2%) were positive by ID-NAT. Most of donors were in age group of 20-29 years & sex ratio of male: female was 70:1.Maximum donors belonged to O blood group. NAT could detect HIV cases in blood donor samples. Its widespread use in blood banks would ensure additional layer of safety in blood transfusion.


Keywords: HIV, ID-NAT, TTIs

Download this article as Download

How to cite this article:

Shalini Priya, A., B. R. Sunitha, K. S. Rajashekar, R. Lava, Mamatha Patil, Savitha Devi and Neelambika. 2021. Individual Donor Nucleic Acid Testing for HIV, HBV and HCV among Blood Donors in A Tertiary Care Hospital.Int.J.Curr.Microbiol.App.Sci. 10(8): 234-239. doi: https://doi.org/10.20546/ijcmas.2021.1008.027
Copyright: This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike license.

Citations